• Select Article Type
  • Abstract Supplements
  • Blood Group Review
  • Call to Arms
  • Hypothesis
  • In Memoriam
  • Interview
  • Introduction
  • Letter to the Editor
  • Short Report
  • abstract
  • Abstracts
  • Article
  • book-review
  • case-report
  • case-study
  • Clinical Practice
  • Commentary
  • Conference Presentation
  • conference-report
  • congress-report
  • Correction
  • critical-appraisal
  • Editorial
  • Editorial Comment
  • Erratum
  • Events
  • Letter
  • Letter to Editor
  • mini-review
  • minireview
  • News
  • non-scientific
  • Obituary
  • original-paper
  • original-report
  • Original Research
  • Pictorial Review
  • Position Paper
  • Practice Report
  • Preface
  • Preliminary report
  • Product Review
  • rapid-communication
  • Report
  • research-article
  • Research Communicate
  • research-paper
  • Research Report
  • Review
  • review -article
  • review-article
  • review-paper
  • Review Paper
  • Sampling Methods
  • Scientific Commentary
  • short-communication
  • short-report
  • Student Essay
  • Varia
  • Welome
  • Select Journal
  • Immunohematology


Article | 10-April-2021

Group O blood donors in Iran: evaluation of isoagglutinin titers and immunoglobulin G subclasses

the fact that some transfusion service providers have a policy against using high-titer plasma components, specifically platelet concentrates, there is still a lack of agreement on the threshold titer value that would lead to an unsafe blood component.6,7 Diet, as well as ethnic and environmental factors, play a contributing role in the level of isoagglutinin titers in different populations; therefore, it is important to determine the frequency of high isoagglutinin titers in each population and

S. Arabi, M. Moghaddam, A.A. Pourfathollah, A. Aghaie, M. Mosaed

Immunohematology, Volume 37 , ISSUE 1, 5–12

Article | 16-February-2021

Quality improvement with platelet additive solution for safer out-of-group platelet transfusions

blood volume during transfusion. If the recipient is a secretor (80% of the population), the soluble A or B blood group substances in the recipient’s plasma can neutralize some anti-A or anti-B isoagglutinins in the donor’s plasma.12,13 This protection becomes ineffective, however, when the recipient is not a secretor or large amounts of anti-A and anti-B are involved.14 In the situation described, a single platelet component with a high isoagglutinin titer can be harmful,8,15–22 and even fatal,8,22

M. Tynuv, W.A. Flegel

Immunohematology, Volume 35 , ISSUE 3, 108–115

No Record Found..
Page Actions